Integrated Partnership With PharmaPros Dataflow Manager Enables New Functionality
FORT LAUDERDALE, Fla., June 25, 2012 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCBB:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced a new level of integration with PharmaPros that provides OmniComm customers with a solution offering next-generation CTMS capabilities for mid-sized organizations interested in a flexible, SaaS solution for clinical trials management. This new integrated solution provides capabilities for Site Management & Monitoring, Budget Tracking & Management, eTMF/Document Tracking, Metrics Portal & Real-time Reporting.
With access to these new tools, OmniComm customers can manage their clinical trial information in a more automated and scalable way. Connecting Trial Master EDC directly to Dataflow Manager through the OmniConnect web-based API eliminates the administrative burden of redundant data entry and reconciliation for clinical Sponsor and CRO organizations across a wide range of eClinical products, reducing trial costs, and providing significant workflow efficiencies.
"We are extremely pleased that OmniComm is now bundling Dataflow Manager's unique study management capabilities with their TrialMaster EDC product," said Brion Regan, Head of Strategic Development, PharmaPros. "We've already seen the benefits within our shared customer base, and have been impressed. OmniComm has proven to be a strong technology partner, with the ability to rapidly address the needs of their customers with value-driven solutions."
This integrated partnership enables OmniComm customers to add Dataflow Manager to their TrialMaster solution on an as-needed or per-trial basis. This flexibility gives customers the ability to quickly scale up or down, based on the needs of the trial, without costly and time-consuming implementations required by traditional CTMS solutions.
"We are excited about this new partnership and the benefits this marriage of EDC and CTMS will provide to our customers," said Stephen Johnson, President and COO of OmniComm. "This integrated partnership and solution is just one more example of how OmniComm is continuing to help our customers connect data across the eClinical spectrum."
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.